Drug
Thymoglobulin
Thymoglobulin: highest development phase Phase 2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Thymoglobulin NCT00709592 | Phase 2 | Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow Thymoglobulin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.